Dr. Rogers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
- Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2009
- Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
- Harvard Medical SchoolClass of 2001
Certifications & Licensure
- CA State Medical License 2013 - 2025
- MA State Medical License 2004 - 2015
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START) Start of enrollment: 2014 Mar 15
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol Start of enrollment: 2021 Apr 23
Publications & Presentations
PubMed
- 394 citationsTreatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.Michael A. Matthay, Carolyn S. Calfee, Hanjing Zhuo, B. Taylor Thompson, Jennifer G. Wilson
The Lancet. Respiratory Medicine. 2019-02-01 - 5595 citationsIntegrated analysis of multimodal single-cell dataYuhan Hao, Stephanie Hao, Erica Andersen-Nissen, William M. Mauck, Shiwei Zheng
Cell. 2021-06-24 - 31 citationsPlasma mitochondrial DNA and metabolomic alterations in severe critical illness.Pär I. Johansson, Kiichi Nakahira, Angela J. Rogers, Michael J. McGeachie, Rebecca M. Baron
Critical Care. 2018-12-29
Press Mentions
- Test Predicts Which COVID-19 Patients Will Grow Worse, Stanford Medicine Study FindSeptember 26th, 2022
- The Proof Is in the Plasma: SARS-CoV-2 Antigen Levels Predict SeverityAugust 30th, 2022
- Scientists Decipher the Danger of Gummy Phlegm in Severe COVID-19June 24th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: